Profil de l'entreprise · Healthcare

Progyny Inc

PGNY · États-Unis
Pays / Région
USA
Date d'introduction en bourse
25 octobre 2019
Effectif
835
Buffett Score
43/100
Faible
Capitalisation1,94 Md $US
Chiffre d'affaires (TTM)1,31 Md $US
EBITDA125,57 M $US
Marge nette6 %
ROE16,24 %
PER (TTM)27,42
PER prévisionnel11,85
BPA0,92 $US
Fourchette sur 52 semaines16,10 $US – 33,07 $US
Objectif de cours des analystes34,42 $US
Recommandation des analystes4.6 / 5

Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Historique

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Position dans le secteur

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Pas encore d'analyse sur cette valeur dans votre langue.